Schrodinger Inc. (SDGR) Acquires XTAL BioStructures for $6M

Go back to Schrodinger Inc. (SDGR) Acquires XTAL BioStructures for $6M

Schrödinger Announces Acquisition of XTAL BioStructures, Inc.

January 18, 2022 6:45 AM EST

Acquisition Expands Schrödingers Leadership in Structure-Based Drug Discovery

NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced the acquisition of XTAL BioStructures, Inc., a private company based in the Greater Boston area that provides structural biology services,... More